Literature DB >> 29345220

Tissue Impression Smears as a Supplementary Diagnostic Method for Histopathology in Cutaneous Leishmaniasis in Sri Lanka.

Nuwani H Manamperi1, M V Chandu de Silva2, Nishantha Pathirana3, Wimal Abeyewickreme4, Nadira D Karunaweera5.   

Abstract

Cutaneous leishmaniasis (CL) is diagnosed mainly by light microscopy of smears made using lesion material. Histopathology is usually done in atypical presentations or when lesion smears are negative. Tissue impression smears (TIS) made from skin biopsy specimens were compared with histopathology for the diagnosis of CL. Out of the 111 patients included, 83 (74.8%) were positive by either methods. The TIS was positive in 70.3% whereas histopathology was positive in 56.8% of patients. Tissue impression smears can be used as a supplementary diagnostic test that gives sensitive and rapid results when tissue biopsies are used as the source of lesion material for diagnosis of CL.

Entities:  

Mesh:

Year:  2018        PMID: 29345220      PMCID: PMC5930914          DOI: 10.4269/ajtmh.17-0748

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Correlation of clinical, parasitological and histopathological diagnosis of cutaneous leishmaniasis in an endemic region in Sri Lanka.

Authors:  R R Ranawaka; P H Abeygunasekara; H S Weerakoon
Journal:  Ceylon Med J       Date:  2012-12

2.  A new focus of cutaneous leishmaniasis in Jammu division of Jammu and Kashmir State, India.

Authors:  Neenu Kaul; Vipin Gupta; Subhash Bhardwaj; Devraj Dogra; Naina Dogra
Journal:  Indian J Dermatol Venereol Leprol       Date:  2016 Mar-Apr       Impact factor: 2.545

3.  Press imprint smear: a rapid, simple, and cheap method for the diagnosis of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.

Authors:  Anastácio Q Sousa; Margarida M L Pompeu; Mércia S Frutuoso; José W O Lima; Juliana M B M Tinel; Richard D Pearson
Journal:  Am J Trop Med Hyg       Date:  2014-08-11       Impact factor: 2.345

4.  Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis.

Authors:  J R Ramírez; S Agudelo; C Muskus; J F Alzate; C Berberich; D Barker; I D Velez
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

5.  Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  Naomi Aronson; Barbara L Herwaldt; Michael Libman; Richard Pearson; Rogelio Lopez-Velez; Peter Weina; Edgar M Carvalho; Moshe Ephros; Selma Jeronimo; Alan Magill
Journal:  Clin Infect Dis       Date:  2016-12-15       Impact factor: 9.079

6.  Value of touch preparations (imprints) for diagnosis of cutaneous leishmaniasis.

Authors:  K A Bahamdan; A R Khan; T M Tallab; M M Mourad
Journal:  Int J Dermatol       Date:  1996-08       Impact factor: 2.736

Review 7.  Is leishmaniasis in Sri Lanka benign and be ignored?

Authors:  N D Karunaweera; U S Rajapaksa
Journal:  J Vector Borne Dis       Date:  2009-03       Impact factor: 1.688

8.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

9.  Skin Scraping is the Most Accessible Technique for the Parasitological Diagnosis of American Tegumentary Leishmaniasis.

Authors:  Cintia X de Mello; Maria de Fátima Madeira
Journal:  Am J Trop Med Hyg       Date:  2015-05       Impact factor: 2.345

10.  Minimally invasive microbiopsies: a novel sampling method for identifying asymptomatic, potentially infectious carriers of Leishmania donovani.

Authors:  Oscar David Kirstein; Ibrahim Abbasi; Ben Zion Horwitz; Laura Skrip; Asrat Hailu; Charles Jaffe; Lynlee L Li; Tarl W Prow; Alon Warburg
Journal:  Int J Parasitol       Date:  2017-04-26       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.